Your browser doesn't support javascript.
loading
Type II non-ribosomal peptide synthetase proteins: structure, mechanism, and protein-protein interactions.
Jaremko, Matt J; Davis, Tony D; Corpuz, Joshua C; Burkart, Michael D.
Afiliação
  • Jaremko MJ; Department of Chemistry and Biochemistry, University of California, 9500 Gilman Drive, La Jolla, San Diego, California 92093-0358, USA. mburkart@ucsd.edu.
  • Davis TD; Department of Chemistry and Biochemistry, University of California, 9500 Gilman Drive, La Jolla, San Diego, California 92093-0358, USA. mburkart@ucsd.edu.
  • Corpuz JC; Department of Chemistry and Biochemistry, University of California, 9500 Gilman Drive, La Jolla, San Diego, California 92093-0358, USA. mburkart@ucsd.edu.
  • Burkart MD; Department of Chemistry and Biochemistry, University of California, 9500 Gilman Drive, La Jolla, San Diego, California 92093-0358, USA. mburkart@ucsd.edu.
Nat Prod Rep ; 37(3): 355-379, 2020 03 25.
Article em En | MEDLINE | ID: mdl-31593192
ABSTRACT
Covering 1990 to 2019 Many medicinally-relevant compounds are derived from non-ribosomal peptide synthetase (NRPS) products. Type I NRPSs are organized into large modular complexes, while type II NRPS systems contain standalone or minimal domains that often encompass specialized tailoring enzymes that produce bioactive metabolites. Protein-protein interactions and communication between the type II biosynthetic machinery and various downstream pathways are critical for efficient metabolite production. Importantly, the architecture of type II NRPS proteins makes them ideal targets for combinatorial biosynthesis and metabolic engineering. Future investigations exploring the molecular basis or protein-protein recognition in type II NRPS pathways will guide these engineering efforts. In this review, we consolidate the broad range of NRPS systems containing type II proteins and focus on structural investigations, enzymatic mechanisms, and protein-protein interactions important to unraveling pathways that produce unique metabolites, including dehydrogenated prolines, substituted benzoic acids, substituted amino acids, and cyclopropanes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo Sintases Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeo Sintases Idioma: En Ano de publicação: 2020 Tipo de documento: Article